Acquisition by Bagger Richard H of 104621 shares of Tonix Pharmaceuticals at 0.1745 subject to Rule 16b-3
| TNXP Stock | USD 0.53 0.29 120.83% |
Slightly above 71 percent of all Tonix Pharmaceuticals' retail investors are curious in acquiring. The analysis of the overall investor sentiment regarding Tonix Pharmaceuticals Holding suggests that quite a few traders are confidant. Tonix Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Tonix Pharmaceuticals Holding. Many technical investors use Tonix Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Tonix |
Filed transaction by Tonix Pharmaceuticals Holding Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
Cash Flow Correlation
Tonix Pharmaceuticals' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Tonix Pharmaceuticals' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Tonix Pharmaceuticals Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Tonix Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Tonix Pharmaceuticals Fundamental Analysis
We analyze Tonix Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tonix Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tonix Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Valuation
Current Valuation Comparative Analysis
Tonix Pharmaceuticals is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Tonix Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tonix Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Tonix Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tonix Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Tonix Pharmaceuticals Related Equities
| SONN | Sonnet Biotherapeutics | 2.26 | ||||
| NVAX | Novavax | 1.00 | ||||
| ENVB | Enveric Biosciences | 0.00 | ||||
| JAGX | Jaguar Animal | 1.02 | ||||
| VXRT | Vaxart | 1.69 | ||||
| VRAX | Virax Biolabs | 1.91 | ||||
| DRUG | Bright Minds | 5.32 | ||||
| IBIO | Ibio | 7.97 | ||||
| PALI | Palisade Bio | 25.00 | ||||
| INO | Inovio Pharmaceuticals | 38.30 |
Additional Tools for Tonix Stock Analysis
When running Tonix Pharmaceuticals' price analysis, check to measure Tonix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tonix Pharmaceuticals is operating at the current time. Most of Tonix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tonix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tonix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tonix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.